Covid Alert


Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2020

Volume: 10 , Issue: 1

Article Access statistics

Viewed: 105

Emailed: 0

PDF Downloaded: 92

Panacea Journal of Medical Sciences


Seroreactivity of hepatitis B and C in a tertiary care hospital ASCOMS


Full Text PDF Share on Facebook Share on Twitter


Research Article

Author Details : Jyoti Kohli, Ajay Puri*, Bella Mahajan

Volume : 10, Issue : 1, Year : 2020

Article Page : 39-42


Suggest article by email

Abstract

Background: Hepatitis B and C are globally emerging health problems. Being Hepatitis B and C are parenterally transmitted viruses both resulting in liver cirrhosis and hepatocellular carcinoma. Both accounting for the substantial proportion of hepatic diseases worldwide. Although both are hepatotropic viruses both are sharing common modes of transmission and mostly affect the young population. Prevalence of Hepatitis B in India is 3.7% and Hepatitis C is 1%. Hepatitis B is the second most common cause of acute viral hepatitis in India. Chance of transmission of Hepatitis B by needle stick injury is 30% and of Hepatitis C is 3%. Intravenous drug abusers were found to be most common mode of transmission of Hepatitis C.
Aims: As both Hepatits B, and C are parenterally transmitted infections and land up into chronicity. To prevent their complications the present study was done to screen out these cases at the very early stage with the test with high sensitivity and specificity.
Materials and Methods: The presence of HBsAg and anti HCV antibodies were studied serologically in patients blood by Electro -chemiluminescence immune-assay method.
Results: The seroreactivity of positive cases were observed.
Conclusion: Henceforth seroreactivity of both the viruses studied among different age groups in both the sexes to initiate the treatment at right time to prevent its long term complications such as chronicity and for good prognosis by highly sensitive and specific test.

Keywords: Anti-HCV antibodies, Electrochemiluminescence immunoassay (ECLIA), Hepatitis B surface antigen (HBsAg), Hepatocellular carcinoma (HCC), Liver cirrhosis.

Doi : 10.18231/j.pjms.2020.010

How to cite : Kohli J, Puri A, Mahajan B, Seroreactivity of hepatitis B and C in a tertiary care hospital ASCOMS. Panacea J Med Sci 2020;10(1):39-42

Copyright © 2020 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)